Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook (2018-2022)
Diabetes devices are used in managing and treating diabetes and the market is filled with a vast variety of these devices. Diabetes devices can be broadly classified into two segments - glucose monitoring devices and insulin delivery devices. Insulin pumps are small, computerized devices that mimic the way the human pancreas works by delivering small doses of short acting insulin continuously. The device is also used to deliver variable amounts of insulin when a meal is eaten. The basal insulin rates are usually set up in pump with doctor, and one can have one or multiple basal settings programmed in the pump.
The global insulin pump market is expected to grow significantly in future due to increasing diabetic population, ageing population and obesity rates. Rise in the global disposable income and healthcare expenditure by the households would push the market in positive direction. In recent years, introduction of patch pumps in the market and increasing adoption of insulin pumps by the diabetic patients helped the market to flourish. Although, stringent legal norms and high cost of treatments could turn out to be a challenge for the market players.
In the U.S., insulin pump market is expected to rise in future. In 2017, the type 1 insulin pump users held the highest share in the U.S. insulin pump market. The insulin pump users would gradually grow in the region due to higher prevalence of diabetes among the population.
In terms of competitive landscape, the major players in the insulin pump market are Medtronic, Roche, Tandem Diabetes Care and Insulet Corporation. In 2017, Medtronic dominated the global insulin pump market in terms of revenue as well as patient share. Medtronic has been focusing on increasing production so as to progress in the global insulin pump market where the market is highly competitive.
The global insulin pump market is expected to grow significantly in future due to increasing diabetic population, ageing population and obesity rates. Rise in the global disposable income and healthcare expenditure by the households would push the market in positive direction. In recent years, introduction of patch pumps in the market and increasing adoption of insulin pumps by the diabetic patients helped the market to flourish. Although, stringent legal norms and high cost of treatments could turn out to be a challenge for the market players.
In the U.S., insulin pump market is expected to rise in future. In 2017, the type 1 insulin pump users held the highest share in the U.S. insulin pump market. The insulin pump users would gradually grow in the region due to higher prevalence of diabetes among the population.
In terms of competitive landscape, the major players in the insulin pump market are Medtronic, Roche, Tandem Diabetes Care and Insulet Corporation. In 2017, Medtronic dominated the global insulin pump market in terms of revenue as well as patient share. Medtronic has been focusing on increasing production so as to progress in the global insulin pump market where the market is highly competitive.
1. OVERVIEW
1.1 Diabetes
1.2 Diabetes Devices
1.3 Insulin Pump
2. GLOBAL INSULIN PUMP MARKET
2.1 Global Diabetes Devices Market Forecast by Value
2.2 Global Diabetes Devices Market by Segment
2.3 Global Insulin Pump Market Forecast by Value
2.4 Global Insulin Pump Market by Type
2.4.1 Global Classic Insulin Pump Market Forecast by Value
2.4.2 Global Patch Insulin Pump Market Forecast by Value
2.5 Global Insulin Pump Patient Volume Forecast
3. THE U.S. INSULIN PUMP MARKET
3.1 The U.S. Type 2 Insulin Users Volume
3.2 The U.S. Type 2 Insulin Users Volume Forecast
3.3 The U.S. Type 2 Insulin Users by Type
3.3.1 The U.S. Type 2 Normal Insulin Users Volume
3.3.2 The U.S. Type 2 Normal Insulin Users Volume Forecast
3.3.3 The U.S. Type 2 Heavy Dose Insulin Users Volume
3.3.4 The U.S. Type 2 Heavy Dose Insulin Users Volume Forecast
3.4 The U.S. Insulin Pump Users Volume
3.5 The U.S. Insulin Pump Users Volume Forecast
3.6 The U.S. Insulin Pump Users by Type
3.6.1 The U.S. Type 1 Insulin Pump Users Volume
3.6.2 The U.S. Type 1 Insulin Pump Users Volume Forecast
3.6.3 The U.S. Type 2 Insulin Pump Users Volume
3.6.4 The U.S. Type 2 Insulin Pump Users Volume Forecast
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Acceleration of Ageing Population
4.1.2 Increasing Obesity Rates
4.1.3 Longer Life Expectancy at Birth
4.1.4 Increasing Disposable Income
4.1.5 Rising Healthcare Expenditure
4.1.6 The U.S. Diabetic Population Forecast
4.2 Key Trends
4.2.1 Adoption of Insulin Pumps
4.2.2 Introduction of Patch Pumps
4.3 Challenges
4.3.1 Stringent Legal Norms
4.3.2 High Cost and Alternative Treatments
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison- Top Players
5.1.2 Global Insulin Pump Market Revenue Share by Company
5.1.3 Global Insulin Pump Patient Volume Share by Company
5.2 The U.S.
5.2.1 The U.S. Insulin Pump Volume Share by Company
5.2.2 The U.S. Type 1 Pump Patient Volume Share by Company
6. COMPANY PROFILES
6.1 Medtronic
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Roche
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Tandem Diabetes Care
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Insulet Corporation
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
1.1 Diabetes
1.2 Diabetes Devices
1.3 Insulin Pump
2. GLOBAL INSULIN PUMP MARKET
2.1 Global Diabetes Devices Market Forecast by Value
2.2 Global Diabetes Devices Market by Segment
2.3 Global Insulin Pump Market Forecast by Value
2.4 Global Insulin Pump Market by Type
2.4.1 Global Classic Insulin Pump Market Forecast by Value
2.4.2 Global Patch Insulin Pump Market Forecast by Value
2.5 Global Insulin Pump Patient Volume Forecast
3. THE U.S. INSULIN PUMP MARKET
3.1 The U.S. Type 2 Insulin Users Volume
3.2 The U.S. Type 2 Insulin Users Volume Forecast
3.3 The U.S. Type 2 Insulin Users by Type
3.3.1 The U.S. Type 2 Normal Insulin Users Volume
3.3.2 The U.S. Type 2 Normal Insulin Users Volume Forecast
3.3.3 The U.S. Type 2 Heavy Dose Insulin Users Volume
3.3.4 The U.S. Type 2 Heavy Dose Insulin Users Volume Forecast
3.4 The U.S. Insulin Pump Users Volume
3.5 The U.S. Insulin Pump Users Volume Forecast
3.6 The U.S. Insulin Pump Users by Type
3.6.1 The U.S. Type 1 Insulin Pump Users Volume
3.6.2 The U.S. Type 1 Insulin Pump Users Volume Forecast
3.6.3 The U.S. Type 2 Insulin Pump Users Volume
3.6.4 The U.S. Type 2 Insulin Pump Users Volume Forecast
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Acceleration of Ageing Population
4.1.2 Increasing Obesity Rates
4.1.3 Longer Life Expectancy at Birth
4.1.4 Increasing Disposable Income
4.1.5 Rising Healthcare Expenditure
4.1.6 The U.S. Diabetic Population Forecast
4.2 Key Trends
4.2.1 Adoption of Insulin Pumps
4.2.2 Introduction of Patch Pumps
4.3 Challenges
4.3.1 Stringent Legal Norms
4.3.2 High Cost and Alternative Treatments
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison- Top Players
5.1.2 Global Insulin Pump Market Revenue Share by Company
5.1.3 Global Insulin Pump Patient Volume Share by Company
5.2 The U.S.
5.2.1 The U.S. Insulin Pump Volume Share by Company
5.2.2 The U.S. Type 1 Pump Patient Volume Share by Company
6. COMPANY PROFILES
6.1 Medtronic
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Roche
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Tandem Diabetes Care
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Insulet Corporation
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
LIST OF CHARTS
Type of Diabetes
Global Diabetes Devices Market Forecast by Value (2017-2022)
Global Diabetes Devices Market by Segment (2017)
Global Insulin Pump Market Forecast by Value (2017-2022)
Global Insulin Pump Market by Type (2017)
Global Classic Insulin Pump Market Forecast by Value (2017-2022)
Global Patch Insulin Pump Market Forecast by Value (2017-2022)
Global Insulin Pump Patient Volume Forecast (2017-2022)
The U.S. Type 2 Insulin Users Volume (2013-2017)
The U.S. Type 2 Insulin Users Volume Forecast (2018-2022)
The U.S. Type 2 Insulin Users by Type (2017)
The U.S. Type 2 Normal Insulin Users Volume (2013-2017)
The U.S. Type 2 Normal Insulin Users Volume Forecast (2018-2022)
The U.S. Type 2 Heavy Dose Insulin Users Volume (2013-2017)
The U.S. Type 2 Heavy Dose Insulin Users Volume Forecast (2018-2022)
The U.S. Insulin Pump Users Volume (2013-2017)
The U.S. Insulin Pump Users Volume Forecast (2018-2022)
The U.S. Insulin Pump Users by Type (2017)
The U.S. Type 1 Insulin Pump Users Volume (2013-2017)
The U.S. Type 1 Insulin Pump Users Volume Forecast (2018-2022)
The U.S. Type 2 Insulin Pump Users Volume (2013-2017)
The U.S. Type 2 Insulin Pump Users Volume Forecast (2018-2022)
Ageing Population above 65 Years (2013-2017)
Global Obese Population (2013-2017)
Global Life Expectancy at Birth (2013-2017)
Global GNI per Capita (2013-2017)
Global Healthcare Expenditure Per Capita (2013-2017)
The U.S. Diabetic Population (2013-2017)
Global Insulin Pump Market Revenue Share by Company (2017)
Global Insulin Pump Patient Volume Share by Company (2017)
The U.S. Insulin Pump Volume by Company (2017)
The U.S. Type 1 Pump Patient Volume by Company (2017)
Medtronic Net Sales by Segment (2018)
Medtronic Net Sales and Net Income (2014-2018)
Medtronic Research and Development Expenditure (2016-2018)
Roche Sales by Segment (2017)
Roche Sales and Net Income (2013-2017)
Roche Research and Development Expenditure (2015-2017)
Tandem Diabetes Care Sales and Net Loss (2013-2017)
Tandem Diabetes Care Research and Development Expenditure (2015-2017)
Insulet Corporation Revenue and Net Loss (2013-2017)
Insulet Corporation Research and Development Expenditure (2015-2017)
Revenue & Market Cap Comparison – Top Players (2018/2017)
Type of Diabetes
Global Diabetes Devices Market Forecast by Value (2017-2022)
Global Diabetes Devices Market by Segment (2017)
Global Insulin Pump Market Forecast by Value (2017-2022)
Global Insulin Pump Market by Type (2017)
Global Classic Insulin Pump Market Forecast by Value (2017-2022)
Global Patch Insulin Pump Market Forecast by Value (2017-2022)
Global Insulin Pump Patient Volume Forecast (2017-2022)
The U.S. Type 2 Insulin Users Volume (2013-2017)
The U.S. Type 2 Insulin Users Volume Forecast (2018-2022)
The U.S. Type 2 Insulin Users by Type (2017)
The U.S. Type 2 Normal Insulin Users Volume (2013-2017)
The U.S. Type 2 Normal Insulin Users Volume Forecast (2018-2022)
The U.S. Type 2 Heavy Dose Insulin Users Volume (2013-2017)
The U.S. Type 2 Heavy Dose Insulin Users Volume Forecast (2018-2022)
The U.S. Insulin Pump Users Volume (2013-2017)
The U.S. Insulin Pump Users Volume Forecast (2018-2022)
The U.S. Insulin Pump Users by Type (2017)
The U.S. Type 1 Insulin Pump Users Volume (2013-2017)
The U.S. Type 1 Insulin Pump Users Volume Forecast (2018-2022)
The U.S. Type 2 Insulin Pump Users Volume (2013-2017)
The U.S. Type 2 Insulin Pump Users Volume Forecast (2018-2022)
Ageing Population above 65 Years (2013-2017)
Global Obese Population (2013-2017)
Global Life Expectancy at Birth (2013-2017)
Global GNI per Capita (2013-2017)
Global Healthcare Expenditure Per Capita (2013-2017)
The U.S. Diabetic Population (2013-2017)
Global Insulin Pump Market Revenue Share by Company (2017)
Global Insulin Pump Patient Volume Share by Company (2017)
The U.S. Insulin Pump Volume by Company (2017)
The U.S. Type 1 Pump Patient Volume by Company (2017)
Medtronic Net Sales by Segment (2018)
Medtronic Net Sales and Net Income (2014-2018)
Medtronic Research and Development Expenditure (2016-2018)
Roche Sales by Segment (2017)
Roche Sales and Net Income (2013-2017)
Roche Research and Development Expenditure (2015-2017)
Tandem Diabetes Care Sales and Net Loss (2013-2017)
Tandem Diabetes Care Research and Development Expenditure (2015-2017)
Insulet Corporation Revenue and Net Loss (2013-2017)
Insulet Corporation Research and Development Expenditure (2015-2017)
Revenue & Market Cap Comparison – Top Players (2018/2017)
